Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

J&J’s Tremfya sees positive results for post-TNFi psoriatic arthritis

June 4, 2021 Medical Communications J&J, JJ

Johnson & Johnson’s interleukin-23 (IL-23) Tremfya (guselkumab) has shown positive results in Phase IIIb trials, in post-tumour necrosis factor (TNF) …
News

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …
Feature

The importance of representation in clinical trials

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …
Feature

Softbox brings in Sean Austerberry as new Director

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Softbox Systems has appointed Sean Austerberry as its Research and Product Development Director. Sean will be responsible for all of …
Appointment
robert_obeirn

Sharp adds Robert O’Beirn to its Global Clinical Services Business

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sharp has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. In early 2019 Mr …
Appointment
deb_hussain

Debra Hussain new CCO of Acacia Pharma

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Acacia Pharma has appointed Debra Hussain as Chief Commercial Officer. She is a highly experienced commercial leader having spent over …
Appointment
natalie_berner

Redx installs Natalie Berner as Non-Executive Director

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Redx Pharma has appointed Natalie Berner as a Non- Executive Director, she will represent RM Special Holdings 3 LLP on …
Appointment

J&J appoints Charmaine England as MD for Consumer Health Northern Europe

June 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 
Appointment
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 28, 2021 Medical Communications

Among our ten most-read stories this week: a French study has found that dogs can detect COVID-19 with 97% accuracy, …
News
az

AstraZeneca’s lung cancer drug gains EU approval

May 28, 2021 Medical Communications AstraZeneca, EU, lung cancer, oncology

AstraZeneca’s Tagrisso (osimertinib) has been approved in the EU for the adjuvant treatment of adult patients with early-stage (IB, II …
News

FDA approves BMS’s Zeposia for chronic inflammatory bowel disease

May 28, 2021 Medical Communications

The FDA has approved Approves Bristol Myers Squibb’s Zeposia for adults with moderately to severely active ulcerative colitis (UC). UC …
News
astrazeneca_sign_sky

EU: Fine AstraZeneca €10 per dose for COVID-19 vaccine delay

May 28, 2021 Medical Communications

The EU is suing AstraZeneca in a Brussels court over its failure to deliver on its vaccine contract. EU member …
News

NICE recommends Janssen’s active psoriatic arthritis drug

May 28, 2021 Medical Communications Janssen, NICE, UK, arthritis

NICE have released a Final Appraisal Document (FAD) recommending Janssen’s tremfya (guselkumab) as a new option for treating active psoriatic …
News
janssen_latest_logo_on_sign_closer

NICE rejects Janssen’s prostate cancer drug Erleada

May 21, 2021 Medical Communications

NICE has published has published draft guidance rejecting Janssen’s Erleada (apalutamide) with androgen deprivation therapy (ADT) for treating prostate cancer. …
News

Australian PM calls for domestic mRNA vaccine production

May 21, 2021 Medical Communications Australia, Moderna, Vaccine, mrna

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026